ancient wisdom · Remedy
Chai Hu Shu Gan Powder
Chai Hu Shu Gan Powder. Ancient TCM prescriptions
📜 Names
Pinyin Name
CHAI HU SHU GAN SAN
中文名 (Chinese)
柴胡舒肝散
English Name
Chai Hu Shu Gan Powder
💊 Form & Use
Category
Ancient TCM prescriptions
Dosage Form
散剂 (Powder)
Administration
Oral
Source / 出处
ETCM
0
Clinical Trials
7
Meta-Analyses
5
PubMed References
Top Conditions Studied with Chai Hu Shu Gan Powder
In general, patients with functional dyspepsia (FD) complain 1
Conventional medicine indicates that the occurrence of pepti 1
Triple-negative breast cancer is relatively rare in the clin 1
The incidence of post-stroke depression is increasing year b 1
Post-stroke depression is one of the common complications of 1
Perimenopausal anxiety disorder (PAD) is one of the main sym 1
Non-alcoholic fatty liver disease (NAFLD) has become the mos 1
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42020164543
Network Meta-analysis of Chinese Patent Medicine Adjuvant Treatment of Post-stroke Depression
Post-stroke depression is one of the common complications of clinical cerebrovas
CRD42021268574
Evidence-Based Study of Traditional Chinese Medicine Compounds or Patent Medicines Combined With Conventional Triple Therapy in the Treatment of Peptic Ulcer: A Systematic Review and Bayesian Network Meta-Analysis
Conventional medicine indicates that the occurrence of peptic ulcer is related t
CRD42020181419
Herbal medicine Siho-sogan-san for functional dyspepsia: Protocol for a systematic review and meta-analysis
In general, patients with functional dyspepsia (FD) complain of postprandial ful
CRD42021266161
Efficacy and safety of Chaihu Shugan Powder for triple-negative breast cancer: a protocol for systematic review and meta‑analysis
Triple-negative breast cancer is relatively rare in the clinic, and the disease
CRD42021286325
Effectiveness of Chaihu-Shugan-San in treatment of Non-alcoholic Fatty Liver Disease: A meta-analysis
Non-alcoholic fatty liver disease (NAFLD) has become the most important chronic
CRD42022303433
Efficacy and Safety of Chaihu Shugan powder in the Treatment of Post Stroke Depression: A Systematic Review and Meta-Analysis
The incidence of post-stroke depression is increasing year by year in China. Pos
📚 Sample References
PMID 29863014
Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways
Neural Regen Res · 2018
PMID 32189432
A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors
J Cell Mol Med · 2020
PMID 34391441
Chaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiota
Chin Med · 2021
PMID 36172180
Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
Front Pharmacol · 2022
PMID 36339629
Chaihu-shugan-san alleviates depression-like behavior in mice exposed to chronic unpredictable stress by altering the gut microbiota and levels of the bile acids hyocholic acid and 7-ketoDCA
Front Pharmacol · 2022